India with over 63 million diabetics represents the world’s second largest diabetes population after China. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.
India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
IMARC’s new report- “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics”, provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and DiabetesDiagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.
The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.
What we have achieved in this report:
Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:
Focus of the Analysis:
•Historical, current and future prevalence of diabetes in India
•Historical, current and future prevalence of type-1 and type-2 diabetes in India
•Historical, current and future prevalence of diabetes in the urban and rural regions in India
•Historical, current and future prevalence of diabetes among males and females in India
•Historical, current and future prevalence of diabetes among various age groups in India
•Historical, current and future diagnosis rates for diabetes in India
•Historical, current and future drug treatment rates for diabetes in India
Comprehensive situation analysis of the Indian Oral Anti-diabetics market and its dynamics:
Focus of the Analysis:
•Performance of the Oral Anti-diabetics market in India
•Performance of key classes
•Performance of key players
•Market outlook
Comprehensive situation analysis of the Indian Insulin market and its dynamics:
Focus of the Analysis:
•Performance of the Insulin market in India
•Performance of key classes
•Performance of key players
•Market outlook
Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:
Focus of the Analysis:
•Performance of the diabetes diagnostics market in India
•Performance of key classes
•Performance of key players
•Market outlook
Information Sources:
Information has been sourced from both primary and secondary sources:
•Primary sources include industry surveys and face to face/telephone interviews with physicians and industry experts.
•Secondary sources include proprietary databases and search engines. These sources include company websites, reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.
Forecasting Methodology:
IMARC generates its product and market forecasts utilizing its extensive database of macroeconomic and sector specific data. The initial baseline forecast is generated with the most recent market data. After an initial baseline forecast, all future macroeconomic and sector specific events and assumptions are taken into account to generate the final forecast.
Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Factors Driving the Diabetes Market in India
4.1 Increasing Obesity Levels
4.2 Urbanization
4.3 India has the Second Largest Diabetes Patient Base in the World
4.4 India Represents One of the Fastest Growing Markets Globally
4.5 Improving Diagnosis and Treatment Rates
5 The Indian Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region (Urban and Rural)
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 Indian Diabetes Market
6.1 Historical Market Trends (2005-2012)
6.2 Market Breakup by Segment (2005-2012)
6.3 The Indian Oral Anti-diabetics Market
6.3.1 Historical Market Trends (2005-2012)
6.3.2 Market Breakup by Class (2005-2012)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2013-2018)
6.4 The Indian Insulin Market
6.4.1 Historical Market Trends (2005-2012)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook (2013-2018)
6.5 Market Outlook (2013-2018)
7 Indian Diabetes Diagnostics Market
7.1.1 Historical Market Trends (2005-2012)
7.1.2 Market Segmentation
7.1.3 Market Shares of Key Players
7.1.4 Market Outlook (2012-2017)
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331
For more information, visit: http://www.imarcgroup.com/indian-diabetes-market-report-epidemiology-patients-prevalence-oral-anti-diabetics-insulin-and-diagnostics/
India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
IMARC’s new report- “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics”, provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and DiabetesDiagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.
The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.
What we have achieved in this report:
Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:
Focus of the Analysis:
•Historical, current and future prevalence of diabetes in India
•Historical, current and future prevalence of type-1 and type-2 diabetes in India
•Historical, current and future prevalence of diabetes in the urban and rural regions in India
•Historical, current and future prevalence of diabetes among males and females in India
•Historical, current and future prevalence of diabetes among various age groups in India
•Historical, current and future diagnosis rates for diabetes in India
•Historical, current and future drug treatment rates for diabetes in India
Comprehensive situation analysis of the Indian Oral Anti-diabetics market and its dynamics:
Focus of the Analysis:
•Performance of the Oral Anti-diabetics market in India
•Performance of key classes
•Performance of key players
•Market outlook
Comprehensive situation analysis of the Indian Insulin market and its dynamics:
Focus of the Analysis:
•Performance of the Insulin market in India
•Performance of key classes
•Performance of key players
•Market outlook
Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:
Focus of the Analysis:
•Performance of the diabetes diagnostics market in India
•Performance of key classes
•Performance of key players
•Market outlook
Information Sources:
Information has been sourced from both primary and secondary sources:
•Primary sources include industry surveys and face to face/telephone interviews with physicians and industry experts.
•Secondary sources include proprietary databases and search engines. These sources include company websites, reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.
Forecasting Methodology:
IMARC generates its product and market forecasts utilizing its extensive database of macroeconomic and sector specific data. The initial baseline forecast is generated with the most recent market data. After an initial baseline forecast, all future macroeconomic and sector specific events and assumptions are taken into account to generate the final forecast.
Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
3.1 What is Diabetes?
3.2 Diabetes Diagnosis and Treatment
3.2.1 Diagnosis
3.2.2 Treatment
3.3 Diabetes Complications
4 Factors Driving the Diabetes Market in India
4.1 Increasing Obesity Levels
4.2 Urbanization
4.3 India has the Second Largest Diabetes Patient Base in the World
4.4 India Represents One of the Fastest Growing Markets Globally
4.5 Improving Diagnosis and Treatment Rates
5 The Indian Diabetes Epidemiology
5.1 Diabetes Population and Prevalence Rates
5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
5.3 Population and Prevalence Rates by Region (Urban and Rural)
5.4 Population and Prevalence Rates by Gender
5.5 Population and Prevalence Rates by Age Group
5.6 Diabetes Diagnosis and Drug Treatment Rates
6 Indian Diabetes Market
6.1 Historical Market Trends (2005-2012)
6.2 Market Breakup by Segment (2005-2012)
6.3 The Indian Oral Anti-diabetics Market
6.3.1 Historical Market Trends (2005-2012)
6.3.2 Market Breakup by Class (2005-2012)
6.3.3 Market Shares of Key Players
6.3.4 Market Outlook (2013-2018)
6.4 The Indian Insulin Market
6.4.1 Historical Market Trends (2005-2012)
6.4.2 Market Breakup by Class
6.4.3 Market Shares of Key Players
6.4.4 Market Outlook (2013-2018)
6.5 Market Outlook (2013-2018)
7 Indian Diabetes Diagnostics Market
7.1.1 Historical Market Trends (2005-2012)
7.1.2 Market Segmentation
7.1.3 Market Shares of Key Players
7.1.4 Market Outlook (2012-2017)
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331
For more information, visit: http://www.imarcgroup.com/indian-diabetes-market-report-epidemiology-patients-prevalence-oral-anti-diabetics-insulin-and-diagnostics/
Comments
Post a Comment